CD45RA Depleted T-cell Infusion for Prevention of Infections After TCRab/CD19-depleted Allo-HSCT

NCT02942173 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Leukemia
Lymphoma
Myelodysplastic Syndromes
GvHD
Opportunistic Infections
Graft-versus-Host Disease

Interventions

BIOLOGICAL: CD45RA-depleted peripheral blood mononuclear cells

Sponsor

Federal Research Institute of Pediatric Hematology, Oncology and Immunology